Advertisement

Topics

Infinity Pharma Appoints Samuel Agresta Chief Medical Officer

17:56 EDT 16 Aug 2018 | Xconomy

Samuel Agresta has been appointed chief medical officer of Cambridge, MA-based Infinity Pharmaceuticals (NASDAQ: INFI). Agresta comes to Infinity from Agios Pharmaceuticals (NASDAQ: AGIO), where he was vice president and head of clinical development. Before Agios, Agresta held posts at Merrimack Pharmaceuticals (NASDAQ: MACK) and Genentech. Following a corporate restructuring last year, Infinity turned its […]

Original Article: Infinity Pharma Appoints Samuel Agresta Chief Medical Officer

NEXT ARTICLE

More From BioPortfolio on "Infinity Pharma Appoints Samuel Agresta Chief Medical Officer"

Advertisement
Quick Search
Advertisement
Advertisement